Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis. (2019)

First Author: Pearson RG
Attributed to:  PTH nasal delivery for the treatment of osteoporosis - TSB NINTTO funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics11060265

PubMed Identifier: 31181662

Publication URI: http://europepmc.org/abstract/MED/31181662

Type: Journal Article/Review

Volume: 11

Parent Publication: Pharmaceutics

Issue: 6

ISSN: 1999-4923